Filter by Category:
INFORMATION
DAY 3
Chaired by: Dr Pranab Haldar (Leicester)
INFORMATION
DAY 3
Chaired by: Professor Liam Heaney (Belfast) and Dr Maisha Jabeen (Oxford)
| 9:00am |
Overcrowding in the asthmatic airway: the consequences of bronchospasm |
| 9:30am |
Greater than the sum of their parts: mast cell – eosinophil interactions in asthma |
| 10:00am | Upside down: epithelial responses to eosinophil targeting Dr Hitasha Rupani (Southampton) |
INFORMATION
DAY 3
Chaired by: Dr Katie Ward (London) and Dr Rahul Mahida (Birmingham)
| 9:00am |
Mechanisms of autoimmunity in ILD |
| 9:30am |
Navigating the spectrum of vasculitis in ILD |
| 10:00am | Phenotyping the myositis patient and tailoring management to specific subtypes Dr Harsha Gunawardena (Bristol) |
INFORMATION
DAY 3
Chaired by: Professor Robert Gray (Glasgow) and Dr Dawn Lau (Cardiff)
| 9:00am |
Covering changing microbial ecology and potential new approached such as phage therapy |
| 9:30am |
What can we learn from large animal models of CF and non-CF Bronchiectasis? |
| 10:00am | Exploring how understanding non-pathogen driven autoinflammation may be the key to treating residual inflammation in the CF lung following CFTR modulator therapy Professor Daniel Peckham (Leeds) |
INFORMATION
DAY 3
Chaired by: Professor Gary Lee (Perth) and Dr Selina Tsim (Glasgow)
| 10:45am |
Genetic mechanisms in pneumothorax and cystic lung diseases |
| 11:15am |
Macrophage subtypes and cellular immunity in pleural infection |
| 11:45am | Pleural septation detection, formation and biology – insights from early phase studies Dr Eihab Bedawi (Oxford) |
INFORMATION
DAY 3
Chaired by: Dr Vicky Moore (Coventry) and Professor Luke Howard (London)
| 10:45am |
Specialist nursing: physiological data within severe asthma, the path to therapeutics |
| 11:15am |
Physiotherapy: physiological data for dysfunctional breathing, a growing evidence base |
| 11:45am |
Physician clinics: physiology data in pulmonary vascular disease, what’s new? |
INFORMATION
DAY 3
Chaired by: Dr Andy Molyneux (Mansfield)
| 10:45am |
New assessment pathways for patients attending hospital with exacerbations of COPD or asthma |
| 11:15am |
Findings from analysis of oxygen safety incidents related to type 2 acute respiratory failure |
| 11:45am |
National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report on pleural procedures |
INFORMATION
DAY 3
INFORMATION
DAY 3
Chaired by: Dr Sonya Craig (Liverpool) and Helen May (Manchester)
| 1:45 pm |
Gender differences in obstructive sleep apnoea |
| 2:15 pm |
MAD plus CPAP: does combining two established treatments for obstructive sleep apnoea give added benefits? |
| 2:45 pm |
Complex sleep apnoea and ASV: evidence, controversies, and patient selection |
INFORMATION
DAY 3
Chaired by: Dr Frances Grudzinska (Nottingham) and Dr Meg Coleman (London)
| 1:45 pm |
Host immune responses and corticosteroid effects in severe CAP |
| 2:15 pm |
Effect of steroids on mortality in patients with severe community-acquired pneumonia: The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial in context |
| 2:45 pm |
NICE guidelines in context – steroids in pneumonia |
INFORMATION
DAY 3
Chaired by: Professor David Lomas (London) and Dr Samantha Walker (ALUK)
| 1:45 pm |
New and known pathological pathways as novel targets during the early phases of chronic respiratory disease |
| 2:15 pm |
Preventing acute microbial-driven exacerbations from destabilising lung function and worsening chronic disease |
| 2:45 pm |
Opportunities for targeting common cross-disease mechanisms to prevent progression of chronic lung diseases |
INFORMATION
DAY 3
Chaired by: Dr Liz Fuller (Newcastle) and Dr Alexandra Teagle (Plymouth)
| 3:30 pm |
Expanding roles of liquid biopsies for lung cancer: detection, residual disease, surveillance and beyond |
| 4:00 pm |
Second primary lung cancers – who is at risk and how long should we follow people up? |
| 4:30 pm |
LungVax: early interception and prevention in the lung cancer setting |
INFORMATION
DAY 3
Chaired by: Professor Alice Turner (Birmingham) and Dr Hannah Burke (Southampton)
| 3:30 pm |
Patient centred innovation – overcoming health inequalities |
| 5:45 pm |
Respiratory innovation and improvement in primary care |
| 4:15 pm |
Driving impact from new therapies |